Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Engineering Liver-Targeted Carbon Dots for Hepatic Injury Therapy.

Created on 10 Nov 2026

Authors

Jing Zhou, Shanshan Pang, Li Qin, Rong Xu, Hongtai Shi, Jianhe Gan

Published in

ACS applied bio materials. Nov 09, 2026. Epub Nov 09, 2026.

Abstract

With growing incidence and limited treatment modalities, drug-induced liver injury (DILI) has become a prominent unmet clinical challenge. Despite being the primary clinical hepatoprotective agent, N-acetylcysteine (NAC) is severely constrained by its insufficient therapeutic efficacy and lack of liver-targeting specificity. Herein, we present the development of liver-targeted carbon dots (HTGN-CDs) as a precision nanotherapeutic against DILI. On the one hand, GN-CDs were synthesized using NAC and glucose as precursors, with NAC incorporation significantly strengthening the antioxidative capacity of CDs. On the other hand, surface functionalization with glycyrrhetinic acid-polyethylene glycol (GA-PEG) endowed the GN-CDs with enhanced hepatocyte-targeting capability, thereby promoting their accumulation in the liver. In vitro assays confirmed the potent antioxidant and anti-inflammatory activity of GN-CDs, while in vivo studies in acetaminophen (APAP)-overdose mice demonstrated that HTGN-CDs significantly reduced hepatocyte necrosis and lowered key biochemical indicator levels, with efficacy superior to the clinical standard NAC. Mechanistically, HTGN-CDs mitigated oxidative stress via the restoration of antioxidant enzyme activity and suppressed inflammation by blocking pro-inflammatory cytokine release and macrophage infiltration. Safety assessments verified excellent biocompatibility of HTGN-CDs, with no detectable hemolytic activity, hematological abnormalities, or organ toxicity observed. Collectively, our findings highlight HTGN-CDs as a promising multifunctional nanotherapeutic for DILI, with substantial potential for clinical translation.

PMID:
43003768
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement